Ligand validation:4WW3

RET: RETINAL

RET is a Ligand Of Interest in 4WW3 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4WW3_RET_B_402	48%	14%	0.221	0.968	1.68	2.31	5	8	0	0	100%	0.9524
4WW3_RET_A_401	41%	11%	0.255	0.973	2.04	2.38	5	8	3	0	100%	0.9524
3AYM_RET_B_1000	52%	14%	0.221	0.981	1.97	2.05	5	8	1	0	100%	0.9524
2Z73_RET_B_1000	48%	21%	0.227	0.974	1.81	1.69	6	6	0	0	100%	0.9524
3AYN_RET_B_1000	40%	30%	0.25	0.963	1.78	1.15	4	4	1	0	100%	0.9524
2ZIY_RET_A_380	0%	12%	0.793	0.757	2.15	2.08	5	7	13	0	100%	0.9524
7XJE_RET_A_301	99%	7%	0.048	0.983	1.99	2.98	4	14	1	0	100%	0.9524
7XJC_RET_A_301	97%	11%	0.067	0.98	1.93	2.43	2	14	0	0	100%	0.7752
7XJD_RET_A_301	97%	11%	0.06	0.972	1.93	2.42	2	14	0	0	100%	0.9524
5ZIN_RET_A_250	96%	7%	0.054	0.964	2.81	2.16	4	10	0	0	100%	0.9524
6TK7_RET_A_301	96%	62%	0.059	0.967	0.85	0.59	1	-	1	0	100%	0.9524

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.